Suntrust Banks’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $3.01M | Buy |
17,785
+1,939
| +12% | +$329K | 0.02% | 471 |
|
|
2019
Q2 | $2.91M | Buy |
15,846
+1,372
| +9% | +$252K | 0.02% | 478 |
|
|
2019
Q1 | $2.66M | Buy |
14,474
+854
| +6% | +$157K | 0.01% | 481 |
|
|
2018
Q4 | $2.26M | Buy |
13,620
+1,062
| +8% | +$176K | 0.01% | 484 |
|
|
2018
Q3 | $2.42M | Buy |
12,558
+3,297
| +36% | +$636K | 0.01% | 503 |
|
|
2018
Q2 | $1.57M | Buy |
9,261
+555
| +6% | +$94.3K | 0.01% | 613 |
|
|
2018
Q1 | $1.42M | Buy |
8,706
+2,603
| +43% | +$424K | 0.01% | 626 |
|
|
2017
Q4 | $914K | Sell |
6,103
-18,310
| -75% | -$2.74M | 0.01% | 715 |
|
|
2017
Q3 | $3.71M | Buy |
24,413
+1,918
| +9% | +$292K | 0.02% | 359 |
|
|
2017
Q2 | $2.9M | Buy |
22,495
+3,126
| +16% | +$403K | 0.02% | 390 |
|
|
2017
Q1 | $2.12M | Sell |
19,369
-1,220
| -6% | -$133K | 0.01% | 456 |
|
|
2016
Q4 | $1.52M | Sell |
20,589
-768
| -4% | -$56.5K | 0.01% | 664 |
|
|
2016
Q3 | $1.86M | Buy |
21,357
+966
| +5% | +$84.2K | 0.01% | 573 |
|
|
2016
Q2 | $1.75M | Sell |
20,391
-1,026
| -5% | -$88.2K | 0.01% | 547 |
|
|
2016
Q1 | $1.7M | Buy |
21,417
+5,961
| +39% | +$473K | 0.01% | 522 |
|
|
2015
Q4 | $1.94M | Buy |
+15,456
| New | +$1.94M | 0.01% | 470 |
|
|
2014
Q2 | – | Sell |
-3,801
| Closed | -$267K | – | 1693 |
|
|
2014
Q1 | $267K | Sell |
3,801
-182
| -5% | -$12.8K | ﹤0.01% | 1640 |
|
|
2013
Q4 | $294K | Sell |
3,983
-1,110
| -22% | -$81.9K | ﹤0.01% | 1531 |
|
|
2013
Q3 | $384K | Sell |
5,093
-25,673
| -83% | -$1.94M | ﹤0.01% | 1364 |
|
|
2013
Q2 | $2.46M | Buy |
+30,766
| New | +$2.46M | 0.01% | 574 |
|